PDS Biotechnology Corporation lost $0.74 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters PDS Biotechnology Corporation has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
PDS Biotechnology Corporation lost $0.74 per diluted share in fiscal year 2025.
PDS Biotechnology Corporation (PDSB) reported a loss of $1.03 per diluted share in fiscal year 2024 and a loss of $0.74 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
PDS Biotechnology Corporation (PDSB) reported -$0.11 in diluted earnings per share in Q3 2026.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what PDS Biotechnology Corporation (PDSB) reported on that line in every period on record.